| Role |
Name |
Disclosure |
Details |
| Author | Hari Polenakovik, MD, Infectious Diseases and General Medicine Consultant Physician, Department of Medicine, Western Health, Footscray, Victoria, Australia | Nothing to disclose | Details | | Coauthor | Sylvia Polenakovik, MD, Clinical Instructor, Internist, Wayne Hospital, Greenville, Ohio, Department of Internal Medicine, Wright State University | Nothing to disclose | Details | | Medical Editor | Wesley W Emmons, MD, FACP, Assistant Professor, Department of Medicine, Thomas Jefferson University; Consulting Staff, Infectious Diseases Section, Department of Internal Medicine, Christiana Care, Newark, DE | Nothing to disclose | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | Managing Editor | Ronald A Greenfield, MD, Professor, Chief, Department of Internal Medicine, Section of Infectious Diseases, University of Oklahoma College of Medicine | Pfizer Gilead Ortho McNeil Wyeth Abbott Astellas Cubicin | Details | | CME Editor | Eleftherios Mylonakis, MD, Clinical and Research Fellow, Department of Internal Medicine, Division of Infectious Diseases, Massachusetts General Hospital | Nothing to disclose | Details | | Chief Editor | Burke A Cunha, MD, Professor of Medicine, State University of New York School of Medicine at Stony Brook; Chief, Infectious Disease Division, Winthrop-University Hospital | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Sylvia Polenakovik, Coauthor |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Wesley W Emmons, Medical Editor |
The contributor discloses no conflict of interest. |
|